Prompt Diagnosis for Timely Management of Hemolytic Disease of The Fetus and Newborn - Expert Pearls for the Practicing Clinician
Activity Learning Objectives:
- Review safety and efficacy profiles for agents being investigated for the treatment of HDFN
- Recognize the clinical presentations of patients that may be at high risk for HDFN for prompt diagnosis and early treatment initiation
- Discuss effective strategies for treatment selection in managing HDFN that also include shared decision-making to promote improved health
Speakers: Washington C. Hill, MD, FACOG, Haywood L. Brown, MD, FACOG, Larry C. Matsumoto, MD, FACOG
Original Credit Type: ACCME, ANCC